[e-drug] Aurobindo To Produce Oral Version Of Nevirapine

e-drug
1

E-DRUG: Aurobindo To Produce Oral Version Of Nevirapine
--------------------------------------------------------

Aurobindo Receives Tentative FDA Approval To Produce Oral Version Of Generic Antiretroviral Nevirapine For PEPFAR
06 Jan 2006
<http://www.kaisernetwork.org>

FDA last week granted tentative approval to Indian drug manufacturer Aurobindo Pharma to produce an oral version of the antiretroviral drug nevirapine for pediatric use under the President's Emergency Plan for AIDS Relief, the <http://www.newkerala.com/news.php?action=fullnews&id=78128&gt;UNI/newKerala\.com reports.

The approval is for 50-milligram/five milliliter oral solution of nevirapine, which is sold under the brand name Viramune by Boehringer Ingelheim (UNI/newKerala.com, 1/3). The tentative approval designation means the drug meets FDA safety and efficacy standards but cannot be sold in the U.S. because of existing patents or exclusivity agreements, although it can be used by relief organizations outside the U.S. under PEPFAR Kaiser Daily HIV/AIDS Report, 6/21/05).

"Reprinted with permission from <http://www.kaisernetwork.org>

You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at <http://www.kaisernetwork.org/dailyreports/healthpolicy&gt;

The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation .

Leela McCullough, Ed.D.
Director of Information Services

SATELLIFE
30 California Street, Watertown, MA 02472, USA
Tel: +617-926-9400 Fax: +617-926-1212
Email: leela@healthnet.org
Web: http://www.healthnet.org